Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 5946

1.

What is the most useful body composition parameter for predicting toxicities of preoperative chemotherapy for gastric cancer?

Hashimoto T, Kurokawa Y, Takahashi T, Saito T, Yamashita K, Tanaka K, Makino T, Yamasaki M, Motoori M, Kimura Y, Nakajima K, Mori M, Doki Y.

Surg Today. 2019 Nov 11. doi: 10.1007/s00595-019-01915-5. [Epub ahead of print]

PMID:
31712913
2.

Itchy body: Topographical difference of itch and scratching and C Nerve fibers.

Hashimoto T, Yosipovitch G.

Exp Dermatol. 2019 Nov 6. doi: 10.1111/exd.14054. [Epub ahead of print]

PMID:
31692114
3.

Diagnosis and outcome of resected solitary pulmonary nodules after liver transplantation.

Tone M, Awano N, Izumo T, Yoshimura H, Jo T, Kuse N, Inomata M, Fukumoto K, Furuhata Y, Hashimoto T, Kumasaka T, Kunitoh H.

Jpn J Clin Oncol. 2019 Nov 5. pii: hyz159. doi: 10.1093/jjco/hyz159. [Epub ahead of print]

PMID:
31688936
4.

Does Exercise Improve False Episodic Memory in Dementia?

Ogoh S, Hashimoto T, Ando S.

J Clin Med. 2019 Nov 1;8(11). pii: E1829. doi: 10.3390/jcm8111829.

5.

DNA-PKcs is activated under nutrient starvation and activates Akt, MST1, FoxO3a, and NDR1.

Shiga S, Murata Y, Hashimoto T, Urushihara Y, Fujishima Y, Kudo K, Sonohara Y, Kurusu M, Takeda K, Jingu K, Hosoi Y.

Biochem Biophys Res Commun. 2019 Nov 1. pii: S0006-291X(19)32035-2. doi: 10.1016/j.bbrc.2019.10.133. [Epub ahead of print]

PMID:
31679687
6.

The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy.

Hashimoto T, Nakashima J, Inoue R, Komori O, Yamaguchi Y, Kashima T, Satake N, Nakagami Y, Namiki K, Nagao T, Ohno Y.

Int J Clin Oncol. 2019 Oct 31. doi: 10.1007/s10147-019-01561-4. [Epub ahead of print]

PMID:
31673831
7.

A case of gastric pseudoaneurysm following endoscopic submucosal dissection of early gastric cancer.

Kobashi R, Hikichi T, Imamura H, Hashimoto T, Mukai S, Ohira H.

Clin J Gastroenterol. 2019 Oct 31. doi: 10.1007/s12328-019-01057-8. [Epub ahead of print]

PMID:
31667719
8.

Dipeptidyl peptidase-4 inhibitor-associated anti-laminin-γ1 (p200) pemphigoid in a patient with psoriasis vulgaris.

Minakawa S, Matsuzaki Y, Hashimoto T, Ishii N, Nishie W, Kayaba H, Sawamura D.

J Dermatol. 2019 Oct 23. doi: 10.1111/1346-8138.15126. [Epub ahead of print] No abstract available.

PMID:
31646656
9.

The facial nerve atrophy with spinal and bulbar muscular atrophy patients (SBMA): Three case reports with 3D fast imaging employing steady-state acquisition (FIESTA).

Miyata M, Kakeda S, Hashimoto T, Korogi Y, Adachi H.

J Neurol Sci. 2019 Nov 15;406:116461. doi: 10.1016/j.jns.2019.116461. Epub 2019 Sep 12. No abstract available.

PMID:
31634716
10.

l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease.

Goshima Y, Masukawa D, Kasahara Y, Hashimoto T, Aladeokin AC.

Front Pharmacol. 2019 Oct 3;10:1119. doi: 10.3389/fphar.2019.01119. eCollection 2019. Review.

11.

[Locally Advanced Gastric Cancer Responding to Neoadjuvant Chemotherapy with Ramucirumab plus Paclitaxel-Case Report].

Matsui H, Shimizu Y, Tachikawa H, Homma T, Mizukami T, Hashimoto T, Abe H.

Gan To Kagaku Ryoho. 2019 Oct;46(10):1565-1567. Japanese.

PMID:
31631140
12.

Mechanisms of itch in stasis dermatitis: Significant role of IL-31 from macrophages.

Hashimoto T, Kursewicz CD, Fayne RA, Nanda S, Shah SM, Nattkemper L, Yokozeki H, Yosipovitch G.

J Invest Dermatol. 2019 Oct 15. pii: S0022-202X(19)33304-4. doi: 10.1016/j.jid.2019.09.012. [Epub ahead of print]

PMID:
31626785
13.

Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood-brain barrier dysfunction module.

Munji RN, Soung AL, Weiner GA, Sohet F, Semple BD, Trivedi A, Gimlin K, Kotoda M, Korai M, Aydin S, Batugal A, Cabangcala AC, Schupp PG, Oldham MC, Hashimoto T, Noble-Haeusslein LJ, Daneman R.

Nat Neurosci. 2019 Nov;22(11):1892-1902. doi: 10.1038/s41593-019-0497-x. Epub 2019 Oct 14.

PMID:
31611708
14.

Basic proline-rich protein-mediated microtubules are essential for lobe growth and flattened cell geometry.

Wong JH, Kato T, Belteton S, Shimizu R, Kinoshita N, Higaki T, Sakumura Y, Szymanski DB, Hashimoto T.

Plant Physiol. 2019 Oct 10. pii: pp.00811.2019. doi: 10.1104/pp.19.00811. [Epub ahead of print]

PMID:
31601644
15.

Analysis of the association between paternity and reoperation for urethral obstruction in adult hypospadias patients who underwent two-stage repair in childhood.

Kanematsu A, Tanaka S, Hashimoto T, Nojima M, Yamamoto S.

BMC Urol. 2019 Oct 4;19(1):88. doi: 10.1186/s12894-019-0512-2.

16.

A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia.

Enomoto T, Tatara A, Goda M, Nishizato Y, Nishigori K, Kitamura A, Kamada M, Taga S, Hashimoto T, Ikeda K, Fujii Y.

J Pharmacol Exp Ther. 2019 Dec;371(3):692-702. doi: 10.1124/jpet.119.260869. Epub 2019 Oct 2.

17.

The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment.

Kumrungsee T, Kariya T, Hashimoto K, Koyano T, Yazawa N, Hashimoto T, Sanada Y, Matsuyama M, Sotomaru Y, Sakurai H, van de Loo FAJ, Yanaka N.

Sci Rep. 2019 Oct 1;9(1):14101. doi: 10.1038/s41598-019-50685-0.

18.

Detection of IgG antibodies to BP180 NC16a and C-terminal domains and LAD-1 in nivolumab-associated bullous pemphigoid.

Matsui Y, Makino T, Ishii N, Hashimoto T, Shimizu T.

Eur J Dermatol. 2019 Sep 30. doi: 10.1684/ejd.2019.3618. [Epub ahead of print] No abstract available.

PMID:
31570332
19.

Nivolumab-associated bullous pemphigoid reactions involving multiple epitopes.

Aoki Y, Miyagawa F, Miyashita K, Nishimura Y, Hashimoto T, Asada H.

Eur J Dermatol. 2019 Sep 30. doi: 10.1684/ejd.2019.3619. [Epub ahead of print] No abstract available.

PMID:
31570326
20.

Intercellular IgA dermatosis aggravated during pregnancy.

Ishikawa T, Munetsugu T, Shinada Y, Yonekura Y, Fujimoto N, Ishii N, Hashimoto T, Satoh T.

Eur J Dermatol. 2019 Sep 25. doi: 10.1684/ejd.2019.3620. [Epub ahead of print] No abstract available.

PMID:
31556875
21.

Edwardsiella tarda Bacteremia, Okayama, Japan, 2005-2016.

Kamiyama S, Kuriyama A, Hashimoto T.

Emerg Infect Dis. 2019 Oct;25(10). doi: 10.3201/eid2510.180518.

22.

Inferring Multidimensional Rates of Aging from Cross-Sectional Data.

Pierson E, Koh PW, Hashimoto T, Koller D, Leskovec J, Eriksson N, Liang P.

Proc Mach Learn Res. 2019 Apr;89:97-107.

23.

Persistence of antienvoplakin and antiperiplakin antibodies in a patient with paraneoplastic pemphigus 20 years after remission.

Riera-Monroig J, Iranzo P, Ishii N, Hashimoto T, Mascaró JM Jr.

Br J Dermatol. 2019 Sep 16. doi: 10.1111/bjd.18534. [Epub ahead of print] No abstract available.

PMID:
31529517
24.

Muscle Stiffness of the Vastus Lateralis in Sprinters and Long-Distance Runners.

Miyamoto N, Hirata K, Inoue K, Hashimoto T.

Med Sci Sports Exerc. 2019 Oct;51(10):2080-2087. doi: 10.1249/MSS.0000000000002024.

PMID:
31525172
25.

In Vivo Expression of NUP93 and Its Alteration by NUP93 Mutations Causing Focal Segmental Glomerulosclerosis.

Hashimoto T, Harita Y, Takizawa K, Urae S, Ishizuka K, Miura K, Horita S, Ogino D, Tamiya G, Ishida H, Mitsui T, Hayasaka K, Hattori M.

Kidney Int Rep. 2019 May 31;4(9):1312-1322. doi: 10.1016/j.ekir.2019.05.1157. eCollection 2019 Sep.

26.

Assessment of fluoride intake from groundwater and intake reduction from delivering bottled water in Chiang Mai Province, Thailand.

Sawangjang B, Hashimoto T, Wongrueng A, Wattanachira S, Takizawa S.

Heliyon. 2019 Sep 5;5(9):e02391. doi: 10.1016/j.heliyon.2019.e02391. eCollection 2019 Sep.

27.

Neutrophil-rich Variant of Persistent Bullous Grover's Disease.

Togo S, Ozawa K, Fujii A, Tanii T, Tsuruta D, Ishii N, Hashimoto T, Tadokoro T, Isei T.

Acta Derm Venereol. 2019 Sep 12. doi: 10.2340/00015555-3316. [Epub ahead of print] No abstract available.

28.

Mass cytometry reveals species-specific differences and a new level of complexity for immune cells in the prostate.

Fox JJ, Navarro HI, Hashimoto T, Garcia AJ, Goldstein AS.

Am J Clin Exp Urol. 2019 Aug 15;7(4):281-296. eCollection 2019.

29.

Net-400-Gbps PS-PAM transmission using integrated AMUX-MZM.

Yamazaki H, Nakamura M, Kobayashi T, Nagatani M, Wakita H, Ogiso Y, Nosaka H, Hashimoto T, Miyamoto Y.

Opt Express. 2019 Sep 2;27(18):25544-25550. doi: 10.1364/OE.27.025544.

PMID:
31510425
30.

Cooperative action of APJ and α1A-adrenergic receptor in vascular smooth muscle cells induces vasoconstriction.

Nagano K, Kwon C, Ishida J, Hashimoto T, Kim JD, Kishikawa N, Murao M, Kimura K, Kasuya Y, Kimura S, Chen YC, Tsuchimochi H, Shirai M, Pearson JT, Fukamizu A.

J Biochem. 2019 Nov 1;166(5):383-392. doi: 10.1093/jb/mvz071.

PMID:
31504625
31.

G-protein-coupled receptor 40 agonist GW9508 potentiates glucose-stimulated insulin secretion through activation of protein kinase Cα and ε in INS-1 cells.

Hashimoto T, Mogami H, Tsuriya D, Morita H, Sasaki S, Kumada T, Suzuki Y, Urano T, Oki Y, Suda T.

PLoS One. 2019 Sep 9;14(9):e0222179. doi: 10.1371/journal.pone.0222179. eCollection 2019.

32.

Contrast Volume and Decline in Kidney Function in Optical Coherence Tomography-Guided Percutaneous Coronary Intervention.

Nemoto T, Minami Y, Sato T, Muramatsu Y, Kakizaki R, Hashimoto T, Oikawa J, Fujiyoshi K, Meguro K, Shimohama T, Tojo T, Ako J.

Int Heart J. 2019 Sep 27;60(5):1022-1029. doi: 10.1536/ihj.18-565. Epub 2019 Sep 4.

33.

Genetic combination risk for schizophrenia.

Oishi K, Niitsu T, Kanahara N, Hashimoto T, Komatsu H, Sasaki T, Takase M, Sato Y, Iyo M.

Schizophr Res. 2019 Aug 30. pii: S0920-9964(19)30376-7. doi: 10.1016/j.schres.2019.08.021. [Epub ahead of print] No abstract available.

PMID:
31477374
34.

In Silico Structural Modeling and Analysis of Elongation Factor-1 Alpha and Elongation Factor-like Protein.

Sakamoto K, Kayanuma M, Inagaki Y, Hashimoto T, Shigeta Y.

ACS Omega. 2019 Apr 23;4(4):7308-7316. doi: 10.1021/acsomega.8b03547. eCollection 2019 Apr 30.

35.

An optimal condition for the evaluation of human brown adipose tissue by infrared thermography.

Nirengi S, Wakabayashi H, Matsushita M, Domichi M, Suzuki S, Sukino S, Suganuma A, Kawaguchi Y, Hashimoto T, Saito M, Sakane N.

PLoS One. 2019 Aug 26;14(8):e0220574. doi: 10.1371/journal.pone.0220574. eCollection 2019.

36.

Refractory Pemphigoid with Autoantibodies to Both BP230 and Laminin gamma1.

Ashida H, Hamada T, Hosokawa Y, Hashimoto T, Nishie W, Ishii N, Nakama T, Kanno T, Ikeda M.

Acta Derm Venereol. 2019 Aug 22. doi: 10.2340/00015555-3294. [Epub ahead of print] No abstract available.

37.

Molecular and clinicopathological analyses of esophageal carcinosarcoma with special reference to morphological change.

Tsuyama S, Saito T, Akazawa Y, Yanai Y, Yatagai N, Akaike K, Hayashi T, Suehara Y, Takahashi F, Takamochi K, Hashimoto T, Kajiyama Y, Tsurumaru M, Fukunaga T, Yao T.

Virchows Arch. 2019 Oct;475(4):415-424. doi: 10.1007/s00428-019-02643-4. Epub 2019 Aug 23.

PMID:
31444625
38.
39.

Evaluation of Treatment Response in Prostate Cancer and Renal Cell Carcinoma Patients Using 11C-choline PET/CT Findings.

Kitajima K, Yamamoto S, Nakanishi Y, Yamada Y, Hashimoto T, Suzuki T, Go S, Kanematsu A, Nojima M, Fujiwara M, Kaida H, Tsurusaki M, Kanda T, Tamaki Y, Yamakado K.

Acta Med Okayama. 2019 Aug;73(4):341-347. doi: 10.18926/AMO/56936.

40.

Clinicopathological characteristics and survival of primary malignant melanoma of the esophagus.

Hashimoto T, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Motoori M, Kimura Y, Nakajima K, Morii E, Mori M, Doki Y.

Oncol Lett. 2019 Aug;18(2):1872-1880. doi: 10.3892/ol.2019.10519. Epub 2019 Jun 21.

41.

Repeated pressurization as a potential cause of deterioration in virus removal by aged reverse osmosis membrane used in households.

Torii S, Hashimoto T, Do AT, Furumai H, Katayama H.

Sci Total Environ. 2019 Aug 9;695:133814. doi: 10.1016/j.scitotenv.2019.133814. [Epub ahead of print]

PMID:
31421339
42.

Facial nerve atrophy in patients with amyotrophic lateral sclerosis: Evaluation with fast imaging employing steady-state acquisition (FIESTA).

Miyata M, Kakeda S, Hashimoto T, Ide S, Okada K, Adachi H, Korogi Y.

J Magn Reson Imaging. 2019 Aug 9. doi: 10.1002/jmri.26890. [Epub ahead of print]

PMID:
31400058
43.

[Determination of Antifungal Drugs in Fish and Livestock Products Using LC-MS/MS].

Nakagawa Y, Kanda M, Hayashi H, Matsushima Y, Ohba Y, Koike H, Nagano C, Sekimura K, Otsuka K, Sasamoto T, Hashimoto T.

Shokuhin Eiseigaku Zasshi. 2019;60(3):52-60. doi: 10.3358/shokueishi.60.52. Japanese.

44.

Expansion of Luminal Progenitor Cells in the Aging Mouse and Human Prostate.

Crowell PD, Fox JJ, Hashimoto T, Diaz JA, Navarro HI, Henry GH, Feldmar BA, Lowe MG, Garcia AJ, Wu YE, Sajed DP, Strand DW, Goldstein AS.

Cell Rep. 2019 Aug 6;28(6):1499-1510.e6. doi: 10.1016/j.celrep.2019.07.007.

45.

Calcium-responsive transactivator (CREST) toxicity is rescued by loss of PBP1/ATXN2 function in a novel yeast proteinopathy model and in transgenic flies.

Park S, Park SK, Watanabe N, Hashimoto T, Iwatsubo T, Shelkovnikova TA, Liebman SW.

PLoS Genet. 2019 Aug 7;15(8):e1008308. doi: 10.1371/journal.pgen.1008308. eCollection 2019 Aug.

46.

Postoperative Long-Term Outcomes in Elderly Patients with Gastric Cancer and Risk Factors for Death from Other Diseases.

Hashimoto T, Kurokawa Y, Mikami J, Takahashi T, Miyazaki Y, Tanaka K, Makino T, Yamasaki M, Motoori M, Kimura Y, Nakajima K, Mori M, Doki Y.

World J Surg. 2019 Nov;43(11):2885-2893. doi: 10.1007/s00268-019-05109-5.

PMID:
31388706
47.

Murine Model of Central Venous Stenosis using Aortocaval Fistula with an Outflow Stenosis.

Isaji T, Ono S, Hashimoto T, Yamamoto K, Taniguchi R, Hu H, Wang T, Koizumi J, Nishibe T, Hoshina K, Dardik A.

J Vis Exp. 2019 Jul 11;(149). doi: 10.3791/59540.

PMID:
31355803
48.

Pathophysiological mechanisms of itch in bullous pemphigoid.

Hashimoto T, Kursewicz CD, Fayne RA, Nanda S, Shah SM, Nattkemper L, Yokozeki H, Yosipovitch G.

J Am Acad Dermatol. 2019 Jul 25. pii: S0190-9622(19)32450-8. doi: 10.1016/j.jaad.2019.07.060. [Epub ahead of print]

PMID:
31351883
49.

Pemphigus foliaceus progressing to bullous pemphigoid.

Iwakura R, Oiso N, Tateishi C, Suzuki M, Uchida S, Yanagihara S, Hashimoto T, Tsuruta D, Kawada A.

J Dermatol. 2019 Nov;46(11):e424-e426. doi: 10.1111/1346-8138.15021. Epub 2019 Jul 25. No abstract available.

PMID:
31342555
50.

Anticomplement therapy in bullous pemphigoid.

Hashimoto T, Kanazawa N, Inoue N.

Br J Dermatol. 2019 Sep;181(3):448-449. doi: 10.1111/bjd.18229. Epub 2019 Jul 21. No abstract available.

PMID:
31328264

Supplemental Content

Loading ...
Support Center